Sunho Biologics Forms Independent Investigation Committee; Trading Halt Continues Pending FY-2025 Results

Bulletin Express05-26

Sunho Biologics, Inc. announced that its Board of Directors resolved on 26 May 2026 to establish an Independent Investigation Committee tasked with conducting a forensic review into previously disclosed matters that have delayed publication of the company’s FY-2025 annual results.

The committee comprises three independent non-executive directors—Mr. Chan Heung Wing Anthony (chairman), Ms. Feng Lan, and Mr. Shi Luwen—and is empowered to oversee all aspects of the investigation, engage external specialists, and approve the firm's quarterly resumption-update announcements.

Trading in Sunho Biologics’ shares has been suspended since 9:00 a.m. on 1 April 2026 and will remain halted until the FY-2025 annual results are released. The company will issue further updates on the progress and findings of the investigation as appropriate. Shareholders and potential investors are urged to exercise caution when dealing in the company’s securities and to seek professional advice when in doubt.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1161361468?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 23:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161361468","market":"us","top_or_hot":-1,"title":"Sunho Biologics Forms Independent Investigation Committee; Trading Halt Continues Pending FY-2025 Results","media":"Bulletin Express","content":"<p>Sunho Biologics, Inc. announced that its Board of Directors resolved on 26 May 2026 to establish an Independent Investigation Committee tasked with conducting a forensic review into previously disclosed matters that have delayed publication of the company’s FY-2025 annual results.</p>\n<p>The committee comprises three independent non-executive directors—Mr. Chan Heung Wing Anthony (chairman), Ms. Feng Lan, and Mr. Shi Luwen—and is empowered to oversee all aspects of the investigation, engage external specialists, and approve the firm's quarterly resumption-update announcements.</p>\n<p>Trading in Sunho Biologics’ shares has been suspended since 9:00 a.m. on 1 April 2026 and will remain halted until the FY-2025 annual results are released. The company will issue further updates on the progress and findings of the investigation as appropriate. Shareholders and potential investors are urged to exercise caution when dealing in the company’s securities and to seek professional advice when in doubt.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sunho Biologics Forms Independent Investigation Committee; Trading Halt Continues Pending FY-2025 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSunho Biologics Forms Independent Investigation Committee; Trading Halt Continues Pending FY-2025 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-26 23:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sunho Biologics, Inc. announced that its Board of Directors resolved on 26 May 2026 to establish an Independent Investigation Committee tasked with conducting a forensic review into previously disclosed matters that have delayed publication of the company’s FY-2025 annual results.</p>\n<p>The committee comprises three independent non-executive directors—Mr. Chan Heung Wing Anthony (chairman), Ms. Feng Lan, and Mr. Shi Luwen—and is empowered to oversee all aspects of the investigation, engage external specialists, and approve the firm's quarterly resumption-update announcements.</p>\n<p>Trading in Sunho Biologics’ shares has been suspended since 9:00 a.m. on 1 April 2026 and will remain halted until the FY-2025 annual results are released. The company will issue further updates on the progress and findings of the investigation as appropriate. Shareholders and potential investors are urged to exercise caution when dealing in the company’s securities and to seek professional advice when in doubt.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02898","symbol_name":"盛禾生物-B","start_time":0,"source_url":"","article_id":"1161361468","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161361468","pubTimestamp":1779807831,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sunho Biologics, Inc. announced that its Board of Directors resolved on 26 May 2026 to establish an Independent Investigation Committee tasked with conducting a forensic review into previously...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02898":"盛禾生物-B"},"translate_title":"Sunho Biologics成立独立调查委员会；交易继续暂停，等待2025财年业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02898":1},"content_text":"Sunho Biologics, Inc. announced that its Board of Directors resolved on 26 May 2026 to establish an Independent Investigation Committee tasked with conducting a forensic review into previously disclosed matters that have delayed publication of the company’s FY-2025 annual results.\nThe committee comprises three independent non-executive directors—Mr. Chan Heung Wing Anthony (chairman), Ms. Feng Lan, and Mr. Shi Luwen—and is empowered to oversee all aspects of the investigation, engage external specialists, and approve the firm's quarterly resumption-update announcements.\nTrading in Sunho Biologics’ shares has been suspended since 9:00 a.m. on 1 April 2026 and will remain halted until the FY-2025 annual results are released. The company will issue further updates on the progress and findings of the investigation as appropriate. Shareholders and potential investors are urged to exercise caution when dealing in the company’s securities and to seek professional advice when in doubt.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1161361468","isCrawlerRequest":true}